SG Americas Securities’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

SG Americas Securities’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,751	Closed	-$126K	–	3694
2022 Q1	$126K	Sell	6,751 -17,822	-73%	-$321K	﹤0.01%	2674
2021 Q4	$526K	Sell	24,573 -15,927	-39%	-$314K	﹤0.01%	2146
2021 Q3	$748K	Buy	+40,500	New	+$815K	﹤0.01%	2159
2021 Q2	–	Sell	-16,615	Closed	-$321K	–	3386
2021 Q1	$321K	Buy	+16,615	New	+$293K	﹤0.01%	2331

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SG Americas Securities's OCDX Position: Q2 2022 in Review

SG Americas Securities sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 6,751 shares — an estimated $126K sold.

SG Americas Securities first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $748K in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

SG Americas Securities reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
SG Americas Securities sold 6,751 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $126K.
SG Americas Securities first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
SG Americas Securities's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $748K in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.